Project Grant R03CA286623
Award Date
8/11/25
Completion Date
7/31/27
Dollars Obligated
$164K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Kentucky, USA
Similar Awards
The National Cancer Institute (NCI) awarded a Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the University of Oklahoma Health Sciences Center to conduct a randomized factorial trial on smoking cessation interventions. The $625,201 award, effective January 1, 2025 through December 31, 2029, will evaluate the combined impact of varenicline medication plus nicotine lozenges, and a smartphone-based medication adherence intervention, on 7-day point prevalence...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports the development and evaluation of a wearable device called "Smokemon" and associated software platform "SmokeDash" to remotely monitor smoking behavior and triggers among cancer survivors. The total award amount is $399,891, with a project period from April 15, 2025 to March 31, 2026. The key products and services to be delivered...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the continuum of risk for tobacco products. The project aims to assess the effects of FDA tobacco product risk continuum messaging on adult combustible tobacco users and youth/young adult tobacco users or...
This $1,389,542 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research program) aims to evaluate population-based strategies for improving smoking cessation among rural populations. The key products and services to be delivered include: A randomized controlled trial (n=544) to determine the efficacy of providing a free nicotine replacement therapy (NRT) starter kit, along with digital NRT education,...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $1,226,040 to the Regents of the University of Minnesota to conduct a randomized clinical trial of a culturally-tailored suite of smoking cessation resources for American Indian persons. The key objectives are to: Co-create a culturally-aligned website, "Smokefree.gov for Natives", to serve as the landing page for digital cessation resources tailored for American...
This Project Grant award of $515,632 from the National Cancer Institute's (NCI) Cancer Cause and Prevention Research program (CFDA 93.393) supports research to prepare the U.S. and state governments for the potential implementation of two cigarette product standards by the FDA - a menthol ban and a nicotine reduction standard. The key objectives are to: 1) Estimate for each U.S. state the increase in people who smoke that would quit and enroll in quit lines following the implementation of...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.077 - Family Smoking Prevention and Tobacco Control Act Regulatory Research provides $188,913 to Virginia Commonwealth University (VCU) from August 1, 2024 to July 31, 2029. The purpose of the grant is to assess perceptions of the continuum of risk among socioeconomically disadvantaged adult smokers, design and test educational messages about the relative risks of...
The federal Project Grant award R21CA292195 was provided by the National Cancer Institute (NCI), which administers the Cancer Cause and Prevention Research (CFDA 93.393) program. The $226,504 award will fund a 2-year study to examine tobacco use behaviors and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities, such as racial/ethnic minorities, sexual/gender minorities, low socioeconomic status, and rural populations. The research aims to...
This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
This $310,319 Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program will support the University of Louisville in conducting formative research to develop a motivation-based adolescent vaping typology to inform the development of tailored cognitive behavioral e-cigarette cessation interventions. The key objectives are to: 1) identify different types of adolescent e-cigarette users based on their motivations for use, 2)...